HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of day-of-injury plasma glial fibrillary acidic protein concentration and six-month posttraumatic stress disorder in patients with mild traumatic brain injury.

Abstract
Several proteins have proven useful as blood-based biomarkers to assist in evaluation and management of traumatic brain injury (TBI). The objective of this study was to determine whether two day-of-injury blood-based biomarkers are predictive of posttraumatic stress disorder (PTSD). We used data from 1143 individuals with mild TBI (mTBI; defined as admission Glasgow Coma Scale [GCS] score 13-15) enrolled in TRACK-TBI, a prospective longitudinal study of level 1 trauma center patients. Plasma glial fibrillary acidic protein (GFAP) and serum high sensitivity C-reactive protein (hsCRP) were measured from blood collected within 24 h of injury. Two hundred and twenty-seven (19.9% of) patients had probable PTSD (PCL-5 score ≥ 33) at 6 months post-injury. GFAP levels were positively associated (Spearman's rho = 0.35, p < 0.001) with duration of posttraumatic amnesia (PTA). There was an inverse association between PTSD and (log)GFAP (adjusted OR = 0.85, 95% CI 0.77-0.95 per log unit increase) levels, but no significant association with (log)hsCRP (adjusted OR = 1.11, 95% CI 0.98-1.25 per log unit increase) levels. Elevated day-of-injury plasma GFAP, a biomarker of glial reactivity, is associated with reduced risk of PTSD after mTBI. This finding merits replication and additional studies to determine a possible neurocognitive basis for this relationship.
AuthorsJacqueline R Kulbe, Sonia Jain, Lindsay D Nelson, Frederick K Korley, Pratik Mukherjee, Xiaoying Sun, David O Okonkwo, Joseph T Giacino, Mary J Vassar, Claudia S Robertson, Michael A McCrea, Kevin K W Wang, Nancy Temkin, Christine L Mac Donald, Sabrina R Taylor, Adam R Ferguson, Amy J Markowitz, Ramon Diaz-Arrastia, Geoffrey T Manley, Murray B Stein, TRACK-TBI Investigators
JournalNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Neuropsychopharmacology) Vol. 47 Issue 13 Pg. 2300-2308 (12 2022) ISSN: 1740-634X [Electronic] England
PMID35717463 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural)
Copyright© 2022. The Author(s).
Chemical References
  • Glial Fibrillary Acidic Protein
  • C-Reactive Protein
  • Biomarkers
Topics
  • Humans
  • Glial Fibrillary Acidic Protein
  • Brain Concussion (complications)
  • Stress Disorders, Post-Traumatic
  • Prospective Studies
  • Longitudinal Studies
  • C-Reactive Protein
  • Brain Injuries, Traumatic (complications)
  • Biomarkers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: